AAV-TAZ Gene Therapy for Barth Syndrome

• Reviewing efforts to translate AAV gene therapy for Barth syndrome, in partnership with the Barth Syndrome Foundation
• Optimizing the preclinical Barth syndrome model and the AAV-TAZ therapeutic candidate vector.

Speakers:

Jennifer Park

Research Assitant

Boston Children’s Hospital at Harvard Medical School